We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TLT.v -- Ignore unavailable to you. Want to Upgrade?

To: Underexposed who wrote (1421)11/12/2019 10:04:24 AM
From: ogi  Read Replies (2) | Respond to of 1645
I am absolutely happy TLT is concentrating on the N.A. market which will be huge $$ potential. Spend money wisely not widely!! Once HC and FDA have approved the PDT here there will be ways to fast track European approval or that could become the work of whoever takes TLT over.We don't need Europe at the moment.

The recall is strictly the therapeutic relief laser for Canada and is not related to the clinical trials.


To: Underexposed who wrote (1421)11/12/2019 11:52:19 AM
From: 3bar  Read Replies (1) | Respond to of 1645
Un thanks for lending your unique expertise to the background on this . The devise division could be very profitable in the long run .

Do you think they would split the company over this or stay the coarse as one ?